Transferring the financial risks of pharmaceutical benefits from a large health care provider in Argentina to a consortium of pharmaceutical companies
Juan C. Cervellino(Universidad de Buenos Aires), Roberto A. Díez(Universidad de Buenos Aires), Rubén Roldán, M. Diana Fligman(Universidad de Buenos Aires), I. Bignone(Universidad de Buenos Aires), Pablo Morici(National Centre for Social research), Sandra B. Corazza(Universidad de Buenos Aires), Santos Andrés Gutiérrez Figueroa(Universidad de Buenos Aires)
Cited by 7
Related Papers
The Phagosome Proteome
|The Journal of Cell Biology|2001|692
RACK1 Competes with HSP90 for Binding to HIF-1α and Is Required for O2-Independent and HSP90 Inhibitor-Induced Degradation of HIF-1α
|Molecular Cell|2007|470
Rab5 regulates the kiss and run fusion between phagosomes and endosomes and the acquisition of phagosome leishmanicidal properties in RAW 264.7 macrophages
|Journal of Cell Science|2000|179
Cytokines in adenoviral disease in children: Association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome
|The Journal of Pediatrics|1994|147
Pre- and Post-Treatment Serum Levels of Cytokines IL-1β, IL-6, and IL-1 Receptor Antagonist in Celiac Disease. Are They Related to the Associated Osteopenia?
|The American Journal of Gastroenterology|1998|146